tirzepatide for menopausal weight gain Menopause, & HRT: The Metabolic “Multiplier" Anti-obesity Medications and Menopausal Hormone
Description
Some patients lose nothing
SGLT2 inhibitors (such as dapagliflozin, empagliflozin, and canagliflozin) are generally well tolerated from a gastrointestinal perspective, though some patients may experience mild abdominal discomfort
Average weight loss in 3 weeks is about 8 pounds for some people
Slow injection: Push the plunger slowly and pause a few seconds before withdrawing the needle to prevent backflow
How Tirzepatide Works Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
